Compared with placebo, dapagliflozin therapy improves the estimated glomerular filtration rate (eGFR) slope from 2 weeks to 12 months of treatment among heart transplant recipients, according to study results presented …
Copyright ©️ 2026 Daily Transplant News | All rights reserved.
Daily Transplant News is published by MatchingDonors.com.